| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. | Director | Voting Common Stock | 156,901 | $381,269 | $2.43 | 22 Sep 2025 | Direct |
| Jasper Therapeutics, Inc. | Director | Common Stock Warrant (right to buy) | 41,000 | 22 Sep 2025 | Direct | ||
| Jasper Therapeutics, Inc. | Director | Stock Option (right to buy) | 7,500 | 03 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JSPR | Jasper Therapeutics, Inc. | 22 Sep 2025 | 2 | +$99,630 | 4 | Director | 24 Sep 2025, 16:01 |
| JSPR | Jasper Therapeutics, Inc. | 03 Jul 2025 | 1 | $0 | 4 | Director | 03 Jul 2025, 16:24 |
| JSPR | Jasper Therapeutics, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 18:25 |
| JSPR | Jasper Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 18:43 |
| JSPR | Jasper Therapeutics, Inc. | 12 Oct 2022 | 1 | $0 | 4 | Director | 13 Oct 2022, 20:03 |
| JSPR | Jasper Therapeutics, Inc. | 21 Mar 2022 | 1 | $0 | 4 | Director | 23 Mar 2022, 18:03 |
| JSPR | Jasper Therapeutics, Inc. | 24 Sep 2021 | 0 | $0 | 3 | Director | 01 Oct 2021, 16:10 |